Financial Performance - The company expects a net profit attributable to shareholders of 580,000,000 CNY for 2024, representing a 114.48% increase compared to the previous year[3] - The net profit after deducting non-recurring gains and losses is projected to be 570,000,000 CNY, reflecting a growth of 118.04% year-on-year[3] - Basic earnings per share are estimated at 1.89 CNY, compared to 0.87 CNY in the same period last year, indicating a significant increase[3] Market Strategy - The company aims to expand market share through enhanced sales of its nutritional products, which have seen increased sales volume and prices compared to the previous year[5] - Future strategies include a focus on integrated, series, and collaborative development, emphasizing "Chemical +" and "Biological +" as core strategic directions[5] - The company is committed to sustainable high-quality development by extending its industrial chain and deepening its global marketing network[6] Technical Development - The company plans to strengthen its technical and industrial platforms, enhancing advanced equipment introduction and cooperation[6] - The company is actively exploring opportunities in strategic emerging industries such as plant protection, new energy, energy conservation, and environmental protection[6] Risk Management - The financial data presented is preliminary and has not been audited by registered accountants, highlighting the need for caution among investors[7] - The company emphasizes a proactive approach to risk management while pursuing growth opportunities in various sectors[5]
新和成(002001) - 2024 Q4 - 年度业绩预告